ArticleHematology, transfusion and cell therapy2024

Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression.

Lucia Vráblová et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.